-+ 0.00%
-+ 0.00%
-+ 0.00%
Marvel Biosciences extends private placement closing deadline to Sept. 14, 2026
Share
Listen to the news
Marvel Biosciences extends private placement closing deadline to Sept. 14, 2026
  • Marvel Biosciences extended the closing deadline for its previously announced private placement to Sept. 14, 2026.
  • The TSX Venture Exchange filing deadline moved from Aug. 31, 2026 to Sept. 14, 2026.
  • All other terms of the offering remained unchanged.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Marvel Biosciences Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609091432NEWSFILECNPR____20260909_313681_1) on September 09, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending